05.04.2022 • News

Neste Studies Scale-up of Chemical Recycling Technology

Neste has announced its intention to conduct a feasibility study on installing new capacity for processing liquefied waste plastic at its refinery in Porvoo, Finland. The move is part of plans to commercialize its chemical recycling technology.

The company expects to make an investment decision in 2023 and gradually implement the technologies in 2024.

The study will look at integrating Neste’s proprietary technologies to pre-treat and upgrade the waste into its refinery operations. The intermediate refining step is needed to remove detrimental impurities and optimize the chemical composition of the material in order to produce drop-in petrochemical feedstock.

A first step will see pre-treatment and upgrading capacity of 400,000 t/y, which Neste said would be a major step toward its target of processing more than 1 million t/y of waste plastic from 2030.

“To turn chemical recycling into a viable and industrial-scale feed source for our downstream partners in the polymers and chemicals value chain, we have to bridge the quality gap between unprocessed liquefied waste plastic oil and our customers’ raw material requirements,” said Mercedes Alonso, executive vice-president renewable polymers and chemicals.

Copyright Neste
Copyright Neste

The Finnish firm has already completed a first series of trial runs to process liquefied waste plastic at Porvoo and addiitional runs with larger volumes will continue this year.

Last October, Neste announced its intention to build its first joint chemical recycling facility with Belgian plastics distributor and compounder Ravago at North Sea Port in Vlissingen, the Netherlands. 

Author: Elaine Burridge, Freelance Journalist

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.